Side Effects of peginterferon alfa-2b injection (sylatron): A Synthesis of Findings from 3 Studies

  1. Home
  2. Side Effects of peginterferon alfa-2b injection (sylatron)
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Side Effects of peginterferon alfa-2b injection (sylatron): A Synthesis of Findings from 3 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of peginterferon alfa-2b injection (sylatron): A Synthesis of Findings from 3 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Main Research Findings

Peginterferon alfa-2b, when used in combination with ribavirin, is effective in treating chronic hepatitis C, but it can also cause a number of side effects. These studies report various side effects, including skin necrosis at the injection site and tongue hyperpigmentation. 1 , 3

Reasons for Side Effects

Peginterferon alfa-2b is a pegylated form of interferon alfa, which has a longer half-life than interferon alfa, allowing for once-weekly injections. This is effective for the treatment of chronic hepatitis C, but it can also cause side effects such as skin reactions and allergic reactions. 1

Common Side Effects

Injection Site Reactions

Skin reactions can occur at the injection site of peginterferon alfa-2b. 1

Skin Necrosis

Skin necrosis can occur at the injection site of peginterferon alfa-2b. 1

Tongue Hyperpigmentation

Tongue hyperpigmentation can occur with combination therapy with peginterferon alfa-2b and ribavirin. 3

Other Side Effects

Combination therapy with peginterferon alfa-2b and ribavirin can cause various skin side effects, such as rash, itching, dry skin, hair loss, and exacerbation of autoimmune diseases. 3

Countermeasures for Side Effects

Injection Site Reactions

If injection site reactions occur, topical treatment such as cold compress or steroid ointment can alleviate symptoms. 1

Skin Necrosis

If skin necrosis occurs, peginterferon alfa-2b administration may need to be discontinued or the dosage may need to be reduced, and topical treatment is also necessary. 1

Tongue Hyperpigmentation

The studies do not specify any specific countermeasures for tongue hyperpigmentation. 3

Other Side Effects

Appropriate treatment should be provided for other side effects, depending on the symptoms. 3

Comparison Between Studies

Similarities in Studies

All of these studies suggest that combination therapy with peginterferon alfa-2b and ribavirin is effective for the treatment of chronic hepatitis C. These studies also suggest that there are side effects associated with combination therapy with peginterferon alfa-2b and ribavirin. 1 , 3

Differences in Studies

These studies differ in the patient populations and study designs. For example, 1 included patients with chronic hepatitis C and chronic myelogenous leukemia, while 3 included only patients with chronic hepatitis C. Also, 2 compared the efficacy and safety of combination therapy with interferon alfa-2b and ribavirin and combination therapy with peginterferon alfa-2b and ribavirin for the treatment of patients co-infected with HIV and hepatitis C.

Notes on Application to Real Life

Peginterferon alfa-2b is an effective drug for the treatment of chronic hepatitis C, but it is important to be aware of the risk of side effects. 1 , 3 When considering peginterferon alfa-2b administration, it is important to consult with a doctor and carefully consider the risks and benefits.

Limitations of Current Research

These studies are relatively small and further research is needed. In particular, further research is needed on the long-term effects of side effects from combination therapy with peginterferon alfa-2b and ribavirin. 1 , 3

Future Research Directions

Further research is needed to better understand the safety and efficacy of combination therapy with peginterferon alfa-2b and ribavirin. In particular, further research is needed on long-term side effects, effectiveness in different patient populations, and optimal dosage and duration of treatment. 1 , 3

Conclusion

Peginterferon alfa-2b is an effective drug for the treatment of chronic hepatitis C, but there is a risk of side effects. 1 , 3 When considering peginterferon alfa-2b administration, it is important to consult with a doctor and carefully consider the risks and benefits.

Literature analysis of 3 papers
Positive Content
2
Neutral Content
0
Negative Content
1
Article Type
1
0
0
0
3
1.

Cutaneous necrosis after injection of polyethylene glycol-modified interferon alfa.

Author: DalmauJoan, PimentelCarmen Lucia, PuigLuis, PeramiquelLaura, RoéEsther, AlomarAgustin

Longer half-life
Superior antiviral efficacy
Cutaneous necrosis
Dose modification required
Local cutaneous reactions

Pegylated interferon alfa-2b can cause local cutaneous reactions at sites of injection. These reactions can range from mild to severe and may require dose modification or treatment withdrawal.

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

2.

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients.

Author: LagunoMontserrat, MurillasJavier, BlancoJosé Luis, MartínezEsteban, MiquelRosa, Sánchez-TapiasJosé M, BargalloXavier, García-CriadoAngeles, de LazzariElisa, LarrousseMaría, LeónAgathe, LoncáMontserrat, MilinkovicAna, GatellJosep M, MallolasJosep

Improved SVR rate
Side effects
Treatment discontinuation

Pegylated interferon alfa-2b (PEG-INF) + ribavirin (RBV) was significantly more effective than interferon alfa-2b (IFN) + RBV for the treatment of chronic hepatitis C in HIV co-infected patients, especially those with genotype 1 or 4.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

3.

Tongue hyperpigmentation resulting from peginterferon alfa-2b and ribavirin treatment in a patient with chronic hepatitis C.

Author: GhoshSouvik, DusejaAjay, DhimanRadha Krishan, ChawlaYogesh Kumar

Tongue hyperpigmentation

Tongue hyperpigmentation has been reported as a side effect of combination therapy with peginterferon alfa (PEG-INF) and ribavirin in patients with hepatitis C virus (HCV) infection.

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.